131 related articles for article (PubMed ID: 9134697)
21. Interaction between PAF and drugs that stimulate formation of inositol phosphates.
Miyamoto A; Kimura H; Ohshika H
Gen Pharmacol; 1991; 22(1):61-5. PubMed ID: 1646747
[TBL] [Abstract][Full Text] [Related]
22. Developmental changes in muscarinic receptor-stimulated phosphoinositide metabolism in rat brain.
Balduini W; Murphy SD; Costa LG
J Pharmacol Exp Ther; 1987 May; 241(2):421-7. PubMed ID: 3033215
[TBL] [Abstract][Full Text] [Related]
23. Estrogen modulates stimulation of inositol phospholipid hydrolysis by norepinephrine in rat brain slices.
Favit A; Fiore L; Nicoletti F; Canonico PL
Brain Res; 1991 Jul; 555(1):65-9. PubMed ID: 1657297
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
Mei L; Lai J; Roeske WR; Fraser CM; Venter JC; Yamamura HI
J Pharmacol Exp Ther; 1989 Feb; 248(2):661-70. PubMed ID: 2537406
[TBL] [Abstract][Full Text] [Related]
25. Age-related alterations in pre-synaptic and receptor-mediated cholinergic functions in rat brain.
Büyükuysal RL; Ulus IH; Kiran BK
Neurochem Res; 1998 May; 23(5):719-26. PubMed ID: 9566611
[TBL] [Abstract][Full Text] [Related]
26. Modulation of muscarinic cholinoceptor-stimulated inositol 1,4,5-trisphosphate accumulation by N-methyl-D-aspartate in neonatal rat cerebral cortex.
Challis RA; Mistry R; Gray DW; Nahorski SR
Neuropharmacology; 1994 Jan; 33(1):15-25. PubMed ID: 7910385
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of alkylating agents on the multiple muscarinic receptor subtypes linked to activation of phospholipase C by carbachol in rat brain cortical membranes.
Sallés J; Wallace MA; Fain JN
J Pharmacol Exp Ther; 1993 Feb; 264(2):521-9. PubMed ID: 8437104
[TBL] [Abstract][Full Text] [Related]
28. Long-term atropine treatment lowers the efficacy of carbachol to stimulate phosphatidylinositol breakdown in the cerebral cortex and hippocampus of rats.
Goobar L; Bartfai T
Biochem J; 1988 Mar; 250(3):727-34. PubMed ID: 3390140
[TBL] [Abstract][Full Text] [Related]
29. Electroconvulsive shock increases alpha 1b- but not alpha 1a-adrenoceptor binding sites in rat cerebral cortex.
Blendy JA; Perry DC; Pabreza LA; Kellar KJ
J Neurochem; 1991 Nov; 57(5):1548-55. PubMed ID: 1681031
[TBL] [Abstract][Full Text] [Related]
30. Aluminum decreases muscarinic, adrenergic, and metabotropic receptor-stimulated phosphoinositide hydrolysis in hippocampal and cortical slices from rat brain.
Shafer TJ; Mundy WR; Tilson HA
Brain Res; 1993 Nov; 629(1):133-40. PubMed ID: 8287268
[TBL] [Abstract][Full Text] [Related]
31. Effects of calcium antagonists on muscarinic receptor subtypes in the rat brain.
Katayama S; Kito S; Miyoshi R; Matsubayashi H
Brain Res; 1987 Sep; 422(1):168-71. PubMed ID: 3676778
[TBL] [Abstract][Full Text] [Related]
32. Modulation by nicotine on binding of cerebral muscarinic receptors with muscarinic agonist and antagonist.
Wang H; Cui WY; Liu CH
Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):497-9. PubMed ID: 9863140
[TBL] [Abstract][Full Text] [Related]
33. [3H]tricyclopinate binding to brain muscarinic acetylcholine receptors: a comparison with [3H]quinuclidinyl benzilate.
Gao ZG; Liu CG
Pharmacol Res; 1996; 33(4-5):283-9. PubMed ID: 8938022
[TBL] [Abstract][Full Text] [Related]
34. Calcium-dependence of histamine- and carbachol-induced inositol phosphate formation in human U373 MG astrocytoma cells: comparison with HeLa cells and brain slices.
Arias-Montaño JA; Berger V; Young JM
Br J Pharmacol; 1994 Feb; 111(2):598-608. PubMed ID: 8004403
[TBL] [Abstract][Full Text] [Related]
35. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
Hussain JF; Kendall DA; Wilson VG
Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
[TBL] [Abstract][Full Text] [Related]
36. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
37. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
Norman AB; Creese I
Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
[TBL] [Abstract][Full Text] [Related]
38. Centpropazine affinity to cortical noradrenergic receptors and effect on their responsiveness in the rat.
Dikshit M; Chalecka-Franaszek E; Nalepa I
J Pharm Pharmacol; 1993 Mar; 45(3):228-30. PubMed ID: 8097784
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of phosphoinositide turnover by selective muscarinic antagonists in the rat striatum. Correlation with receptor occupancy.
Monsma FJ; Abood LG; Hoss W
Biochem Pharmacol; 1988 Jun; 37(12):2437-43. PubMed ID: 2839194
[TBL] [Abstract][Full Text] [Related]
40. Muscarinic receptors in developing rat colon.
Zhang L
Eur J Pharmacol; 1996 May; 304(1-3):211-9. PubMed ID: 8813604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]